![Jay Backstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 31/07/2026
En la actualidad, Jay T. Backstrom ocupa el cargo de Vicepresidente Ejecutivo y Jefe de Investigación y Desarrollo de Acceleron Pharma, Inc. También forma parte del consejo de Autolus Therapeutics Plc. En su anterior carrera profesional ocupó el cargo de Director Médico del Samuel U. Rodgers Community Health Center, Inc., Director Médico de Celgene Corp., Director Ejecutivo-Servicios Médicos y Científicos de Quintiles, Inc. (California) y Vicepresidente Médico y de Seguridad Global en Pharmion Corp. Se doctoró en la Facultad de Medicina de la Universidad de Temple y se graduó en la Facultad de Salud Pública de la Universidad de San Luis.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/03/2025 | 76.277 ( 0,07 % ) | 4 M $ | 31/07/2026 | |
| 08/07/2026 | 1.447 ( 0 % ) | 43 439 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 08/07/2025 |
Be Biopharma, Inc.
 Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Director/Miembro de la Junta | 16/12/2021 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Director/Miembro de la Junta | 01/12/2021 |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Director/Miembro de la Junta | 01/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| LAVA THERAPEUTICS | Director/Miembro de la Junta | 07/11/2025 |
| SCHOLAR ROCK HOLDING CORPORATION | Director Ejecutivo | 27/04/2025 |
| DISC MEDICINE, INC. | Director/Miembro de la Junta | 09/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Director/Miembro de la Junta | 28/02/2023 |
| ACCELERON PHARMA INC. | Director Técnico/Científico/I+D | 01/12/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Samuel U. Rodgers Community Health Center, Inc.
 Samuel U. Rodgers Community Health Center, Inc. Samuel U. Rodgers Community Health Center, Inc. is a federally qualified nonprofit health organization dedicated to providing affordable healthcare to over 23,000 individuals annually. The private company is based in Kansas City, MO. Established in 1968, the center offers comprehensive services for all ages, including medical care, behavioral health counseling, dental and vision care, telehealth, and health insurance assistance. It provides integrated physical and mental health support, specialized programs for men’s health and maternal and infant health, and services accessible regardless of insurance status. The center is expanding its facilities to address primary care shortages and improve access for vulnerable children, and offers patient education resources, interpretation services in over 40 languages, and community partnerships to enhance care accessibility. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
St Louis University School of Public Health
 St Louis University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Lewis Katz School of Medicine
 Lewis Katz School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
